Resveratrol on the Metabolic Reprogramming in Liver: Implications for Advanced Atherosclerosis

Resveratrol on the Metabolic Reprogramming in Liver: Implications for Advanced Atherosclerosis

Background/Aims: Atherosclerosis (AS) is one of the major leading causes of death globally, which is highly correlated with metabolic abnormalities. Resveratrol (REV) exerts beneficial effects on atherosclerosis. Our aim is to clarify the involvement of liver metabolic reprogramming and the atheropr...

Full description

Bibliographic Details
Main Authors: Ying Ma, Dongliang Li, Wenfeng Liu, Xiaoxiao Liu, Yingqi Xu, Xinrui Zhong, Fengnan Zhi, Xueling Jia, Yanan Jiang, Yuhua Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-10-01
Series:Frontiers in Pharmacology
Subjects:
resveratrol
atherosclerosis
liver metabolomics
lipid accumulation
metabolites
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.747625/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.747625/full

Similar Items